shortagewatch

Home / Genito-urinary system and sex hormones / Norethisterone and Ethinylestradiol

ATC G03AA05 · Progestogens and Estrogens, Fixed Combinations

Norethisterone and Ethinylestradiol shortage

As of 2 Nov 2026, Norethisterone and Ethinylestradiol has a reported shortage in 2 of the 15 countries we track (Canada, Japan), covering 5 products from 2 companies.

Countries2/15
Products5packs or presentations
Companies22 listed
Short since6 Jun 202517 months ago
Earliest return19 Mar 2027company estimate
Main reasonManufacturing problem

Timeline

CanadaJapan
20262027BREVICON 0.5/35 TABLETS (28-DAY PACK) (28's)BREVICON 0.5/35 TABLETS (28-DAY PACK) (28's)BREVICON 1/35 TABLETS (28-DAY PACK) (1x28)BREVICON 1/35 TABLETS (28-DAY PACK) (1x28)BREVICON 0.5/35 TABLETS (21-DAY PACK) (1x21)BREVICON 0.5/35 TABLETS (21-DAY PACK) (1x21)BREVICON 1/35 TABLETS (21-DAY PACK) (1x21)BREVICON 1/35 TABLETS (21-DAY PACK) (1x21)フリウェル配合錠LD「トーワ」フリウェル配合錠LD「トーワ」today

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
Pfizer4 PFETowa (Pensa)1 4553

Listed: Pfizer PFE · NYSE, Towa (Pensa) 4553 · Tokyo

Compared with similar medicines

ATC group G03AA · Progestogens and Estrogens, Fixed Combinations
Drospirenone and Ethinylestradiol5/15Levonorgestrel and Ethinylestradiol3/15Norethisterone and Ethinylestradiol2/15Desogestrel and Ethinylestradiol1/15Drospirenone and Estetrol1/15Gestodene and Ethinylestradiol1/15Norgestimate and Ethinylestradiol1/15

Affected products

CountryProductCompanySinceExpected backReason
CABREVICON 0.5/35 TABLETS (28-DAY PACK) (28's)PFIZER CANADA ULC6 Jun 202519 Mar 2027Manufacturing problem
Disruption of the manufacture of the drug
CABREVICON 1/35 TABLETS (28-DAY PACK) (1x28)PFIZER CANADA ULC2 Jan 202619 Mar 2027Manufacturing problem
Disruption of the manufacture of the drug
CABREVICON 0.5/35 TABLETS (21-DAY PACK) (1x21)PFIZER CANADA ULC17 Mar 202619 Mar 2027Manufacturing problem
Disruption of the manufacture of the drug
CABREVICON 1/35 TABLETS (21-DAY PACK) (1x21)PFIZER CANADA ULC19 Jun 202619 Mar 2027Manufacturing problem
Disruption of the manufacture of the drug
フリウェル配合錠LD「トーワ」 limited東和薬品1 Oct 2025not givenManufacturing problem

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.